NeuroMag™ | Magnesíum L-Threonite fyrir hugræna starfsemi | Heilsubarinn

NeuroMag™ | Magnesíum L-Threonite fyrir hugræna starfsemi

9.150 kr

NeuroMag™ | Magnesíum L-Threonite fyrir hugræna starfsemi

9.150 kr
Thumbnail for NeuroMag™ | Magnesíum L-Threonite fyrir hugræna starfsemi | Heilsubarinn Thumbnail for NeuroMag™ | Magnesíum L-Threonite fyrir hugræna starfsemi | Heilsubarinn
NeuroMag™ | Magnesíum L-Threonite fyrir hugræna starfsemi | Heilsubarinn
NeuroMag™ | Magnesíum L-Threonite fyrir hugræna starfsemi | Heilsubarinn

NeuroMag™ | Magnesíum L-Threonite fyrir hugræna...

9.150 kr

• Magtein® Magnesium L-Threonate
• Einkaleyfisvarið form magnesíums
• Magnesíum er samþáttur fyrir 300+ ensímferla
• Mjög lífvirkt form
• 90 hylki

Frí sending yfir 15 þúsund krónur. Pantanir eru afgreiddar samdægurs ef pantað er fyrir kl. 13, annars daginn eftir (virka daga). Ekki er afgreitt um helgar. Þær eru afhentar með Dropp, á þann stað sem þú velur.

Örugg greiðslulausn með Saltpay eða Netgíró.

Auðveld skil með Dropp.
Nánari Lýsing

NeuroMag™ notar hið sérstaka, einkaleyfisvarða steinefni Magtein® (Magnesium L-Threonate).

Þetta er mjög lífvirk uppspretta magnesíums sem getur auðveldað flutning yfir blóð-heila þröskuld. Magnesium L-Threonate getur þannig stutt við hækkuð magnesíum gildi í heilanum.

Magnesium er ómissandi næringarefni og er hjálparefnisþáttur fyrir meira en 300 ensímferla sem styðja við eðlilega lífeðlisfræði líkamans.

Notkun þessa forms magnesíums er ætlað til að styðja við heilbrigði heila og stuðla að eðlilegri hugrænni starfsemi.

Fyrir Hverja:
Þetta bætiefni getur hentað einstaklingum sem leita að sérhæfðum stuðningi við hugræna frammistöðu, minni og almenna heilaheilsu

ÍTARLEGRI UPPLÝSINGAR

Takið þrjár hylki á dag eða samkvæmt leiðbeiningum heilbrigðisstarfsmanns. (Mælt er með að skipta skömmtunum upp.)

1. Office of Dietary Supplements. Magnesium. U.S. Department of Health & Human Services. National Institutes of Health Office of Dietary Supplements. https://ods.od.nih.gov/factsheets/Magnesium‑HealthProfessional/. Accessed March 23, 2022.

2. Fiorentini D, Cappadone C, Farruggia G, Prata C. Magnesium: biochemistry, nutrition, detection, and social impact of diseases linked to its deficiency. Nutrients. 2021;13(4):1136. doi:10.3390/nu13041136.

3. Cordain L, The nutritional characteristics of a contemporary diet based upon paleolithic food groups. JANA 2002;5(3):14‑24.

4. Grochowski C, Blicharska E, Baj J, et al. Serum iron, magnesium, copper, and manganese levels in alcoholism: a systematic review. Molecules. 2019;24(7):1361. doi:10.3390/molecules24071361.

5. Robberecht H, Verlaet AAJ, Breynaert A, De Bruyne T, Hermans N. Magnesium, iron, zinc, copper and selenium status in attention‑deficit/hyperactivity disorder (ADHD). Molecules. 2020;25(19):4440. doi:10.3390/molecules25194440.

6. Liu G, Weinger JG, Lu ZL, Xue F, Sadeghpour S. Efficacy and safety of MMFS‑01, a synapse density enhancer, for treating cognitive impairment in older adults: a randomized, double‑blind, placebo‑controlled trial. J Alzheimers Dis. 2016;49:971‑990. https://pubmed.ncbi.nlm.nih.gov/26519439/.

7. Wroolie TE, Chen K, Watson KT, et al. An 8‑week open label trial of L‑threonic acid magnesium salt in patients with mild to moderate dementia. Personalized Medicine in Psychiatry. 2017;4‑6:7‑12. doi:10.1016/j.pmip.2017.07.001.

8. Surman C, Vaudreuil C, Boland H, Rhodewalt L, DiSalvo M, Biederman J. L‑threonic acid magnesium salt supplementation in ADHD: an open‑label pilot study. Journal of Dietary Supplements. 2020;18(2):119‑131. doi:10.1080/19390211.2020.1731044.

9. Slutsky I, Abumaria N, Wu LJ, Huang C, Zhang L, Li B, et al. Enhancement of learning and memory by elevating brain magnesium. Neuron. 2010;65:165‑177. https://pubmed.ncbi.nlm.nih.gov/20152124/.

10. Li W, Yu J, Liu Y, et al. Elevation of brain magnesium prevents and reverses cognitive deficits and synaptic loss in Alzheimer’s disease mouse model. J Neurosci. 2013;33(19):8423‑8441. doi:10.1523/jneurosci.4610‑12.2013.

11. Wang J, Liu Y, Zhou LJ, Wu Y, Li F, Shen KF. Magnesium L‑threonate prevents and restores memory deficits associated with neuropathic pain by inhibition of TNF‑α. Pain Physician. 2013;5;16(5;9). doi:10.36076/ppj.2013/16/e563.

12. Sun Q, Weinger JG, Mao F, Liu G. Regulation of structural and functional synapse density by L‑threonate through modulation of intraneural magnesium concentration. Neuropharmacol. 2016;108:426‑439.

13. Jia S, Liu Y, Shi Y, Ma Y, Hu Y, Wang M, et al. Elevation of brain magnesium potentiates neural stem cell proliferation in the hippocampus of young and aged mice. J Cell Physiol. 2016;231(19):1903‑1912.

14. Bislimi K, Mazreku I, Halili J, Aliko V, Sinani K, Hoxha L. Effects of vitamin c and magnesium l‑threonate treatment on learning and memory in lead‑poisoned mice. J Vet Res. 2021;65(2):217‑223. doi:10.2478/jvetres‑2021‑0032.

15. Yu X, Guan PP, Guo JW, et al. By suppressing the expression of anterior pharynx‑defective‑1α and ‑1β and inhibiting the aggregation of β‑amyloid protein, magnesium ions inhibit the cognitive decline of amyloid precursor protein/presenilin 1 transgenic mice. FASEB J. 2015;29(12):5044‑5058. doi:10.1096/fj.15‑275578.

16. Wang P, Yu X, Guan PP, Guo JW, Wang Y, Zhang Y, et al. Magnesium ion influx reduces neuroinflammation in AB precursor protein/Presenilin 1 transgenic mice by suppressing the expression of interleukin‑1B. Cell Mol Immunol. 2017;14:451‑464. doi:10.1038/cmi.2015.93.

17. Yu X, Guan PP, Zhu D, et al. Magnesium ions inhibit the expression of tumor necrosis factor α and the activity of γ‑secretase in a β‑amyloid protein‑dependent mechanism in APP/PS1 transgenic mice. Front Mol Neurosci. 2018;11:172. doi:10.3389/fnmol.2018.00172.

18. Huang Y, Huang X, Zhang L, et al. Magnesium boosts the memory restorative effect of environmental enrichment in Alzheimer’s disease mice. CNS Neurosci Ther. 2018;24(1):70‑79. doi:10.1111/cns.12775.

19. Shen Y, Dai L, Tian H, et al. Treatment of magnesium‑L‑threonate elevates the magnesium level in the cerebrospinal fluid and attenuates motor deficits and dopamine neuron loss in a mouse model of Parkinson’s disease. Neuropsychiatr Dis Treat. 2019;15:3143‑3153. doi:10.2147/NDT.S230688.

20. Liu C, Cheng Y, Guo Y, Qian H. Magnesium‑L‑threonate alleviate colonic inflammation and memory impairment in chronic‑plus‑binge alcohol feeding mice. Brain Res Bull. 2021;174:184‑193. doi:10.1016/j.brainresbull.2021.06.009.

21. Sadir S, Tabassum S, Emad S, et al. Neurobehavioral and biochemical effects of magnesium chloride (MgCl2), magnesium sulphate (MgSO4) and magnesium‑L‑threonate (MgT) supplementation in rats: a dose dependent comparative study. Pak J Pharm Sci. 2019;32(1 suppl):277‑283. https://pubmed.ncbi.nlm.nih.gov/30829204/

22. Zhou X, Huang Z, Zhang J, et al. Chronic oral administration of magnesium‑l‑threonate prevents oxaliplatin‑induced memory and emotional deficits by normalization of TNF‑α/NF‑κB signaling in rats. Neurosci Bull. 2021;37(1):55‑69. doi:10.1007/s12264‑020‑00563‑x.

23. Chen JL, Zhou X, Liu BL, et al. Normalization of magnesium deficiency attenuated mechanical allodynia, depressive‑like behaviors, and memory deficits associated with cyclophosphamide‑induced cystitis by inhibiting TNF‑α/NF‑κB signaling in female rats [published correction appears in J Neuroinflammation. 2021 Nov 14;18(1):269]. J Neuroinflammation. 2020;17(1):99. Published 2020 Apr 2. doi:10.1186/s12974‑020‑01786‑5.

24. Zhang J, Mai CL, Xiong Y, et al. The causal role of magnesium deficiency in the neuroinflammation, pain hypersensitivity and memory/emotional deficits in ovariectomized and aged female mice. J Inflamm Res. 2021;14:6633‑6656. doi:10.2147/JIR.S330894.


© 2026 Heilsubarinn ehf. Allur réttur áskilinn.